January 1, 2001
View Full PaperLow-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis
Key Points
Key points are not available for this paper at this time.
Abstract
Methotrexate plus vinblastine given every 7-10 days for several months is associated with prolonged stable disease in a substantial subset of patients with advanced (inoperable) aggressive fibromatosis.